Jason Lewis Radiochem MSK

Final call for abstracts! This week is the last chance to submit your abstract for the Cancer Grand Challenges Conference: Cancer and the host cancergrandchallenges.org/conferences/ca… 🚨 Submit by Friday 20 March for the opportunity to join an outstanding line-up of speakers #CancerGrandChallenges #CancerResearch

Dear SNMMI Colleagues: My name will be on the SNNMI ballot for Vice-President Elect (SNNMI President 2028-2029). Voting starts March 30th. If you are a member of the SNMMI, I am hoping you will consider voting for me. My platform statement will be on the ballot. Thank you!

A clinically relevant roadmap for translating CLDN18.2-targeted immuno-PET and radiotherapy for patients with HER2-negative gastric cancer: ow.ly/UgsG50YpNL8. #NuclearMedicine #RPTherapy #GastricCancer @TheZeglisLab @YJanjigianMD @LewisLabMSKCC

Fabulous visit to Riken in Tokyo today - and the most impressive cyclotron I have ever seen….

The “Cycletrons” (the best name ever!) raising money for an amazing cause - curing rare cancer!! @MSKCancerCenter @Equinox @Cycle4Survival

Read our latest - out now at EJNMMI “Minimal chemical modification enables alpha/beta radiolabeling of sacituzumab govitecan for targeted therapy in high grade serous ovarian cancer”. rdcu.be/e6awn

Our latest “Efficacy of CLDN18.2-Targeted Radiotheranostics in Patient-Derived Models of Gastric Cancer” jnm.snmjournals.org/content/early/…

The “Cycletrons” are participating in @Cycle4Survival to raise money for rare cancer research at @MSKCancerCenter, and your support would mean so much to us. Make a 100% tax-deductible donation using the link. Thank you! secure2.convio.net/mskcc/site/TR?…

What's next in DLL3-targeted therapy for NECs...? Maybe this... pnas.org/doi/10.1073/pn…

Proud to see our work featured: a DLL3-targeted theranostic approach from @MSKCancerCenter combining PET imaging and targeted therapy for aggressive small cell lung and neuroendocrine prostate cancers.⁦@MSKCancerCenter⁩ ⁦@LewisLabMSKCC⁩ mskcc.org/news/new-imagi…

Very proud to share our full discovery campaign identified a next-generation DLL3 antibody that outperformed first-gen antibodies in imaging and therapy with minimal toxicity. Huge thanks to our incredible co-authors and @PCFnews for making this possible! pnas.org/doi/10.1073/pn…

Next-generation anti-DLL3 radiopharmaceuticals targeting high-grade neuroendocrine lung and prostate cancers | PNAS pnas.org/doi/10.1073/pn…

This was actually really interesting to do and to look back and reflect “Leading Through Change: Reflections from Jason Lewis” jnm.snmjournals.org/content/early/…

The final paper from his thesis is out ! - Dr. Justin Hachey - Exploring the 89Zr/177Lu Theranostic Pairing with an Extracellular Matrix Targeted Radiopharmaceutical Against Triple Negative Breast Cancer. aacrjournals.org/clincancerres/…

Our latest “Radiolabeling of CHX-A″-DTPA-Antibody Conjugates with [89Zr]ZrCl4” jnm.snmjournals.org/content/67/1/1…

This was a lot of fun to do with ⁦@ProfKHerrmann⁩ along with ⁦@thomashopemd⁩ ⁦@IreneBuvat⁩. Happy New Year!! youtu.be/Kxibmu8tRaE

The Lewis Lab annual Thai Food - Secret Santa luncheon. @LewisLabMSKCC

Congratulations to Dr. Jason Lewis, a radiochemist and Deputy Director of the Sloan Kettering Institute at MSK, for being elected as a Fellow of the @AcadofInventors, a prestigious honor recognizing individuals who have demonstrated innovation and made tangible contributions to the advancement of technology and society. Learn more: bit.ly/4iORmBq

@AcadofInventors So honored to be named a 2025 Fellow!

The National Academy of Inventors is proud to announce the 2025 Class of Fellow inductees! This distinguished group includes 169 U.S. Fellows and 16 International Fellows, representing 127 research universities, government agencies, and non-profit institutions around the world. Together, they hold more than 5,300 U.S. patents, with their groundbreaking work spanning fields such as quantum computing, artificial intelligence, regenerative medicine, and more. They join a global community of NAI Fellows — now 2,253 strong — who collectively hold over 86,000 U.S. patents and 20,000 licensed technologies. These exceptional inventors will be honored at the 15th Annual Conference of the National Academy of Inventors, taking place June 1-4, 2026, in Los Angeles, California. Join us in celebrating these trailblazing innovators. Learn more about the NAI Fellows Class of 2025 here: academyofinventors.org/nai-welcomes-2… #NAI #NAIFellow